What Ever Happened to N‐of‐1 Trials? Insiders' Perspectives and a Look to the Future
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Context:When feasible, randomized, blinded single‐patient (n‐of‐1) trials are uniquely capable of establishing the best treatment in an individual patient. Despite early enthusiasm, by the turn of the twenty‐first century, few academic centers were conducting n‐of‐1 trials on a regular basis. Methods:The authors reviewed the literature and conducted in‐depth telephone interviews with leaders in the n‐of‐1 trial movement. Findings:N‐of‐1 trials can improve care by increasing therapeutic precision. However, they have not been widely adopted, in part because physicians do not sufficiently value the reduction in uncertainty they yield weighed against the inconvenience they impose. Limited evidence suggests that patients may be receptive to n‐of‐1 trials once they understand the benefits. Conclusions:N‐of‐1 trials offer a unique opportunity to individualize clinical care and enrich clinical research. While ongoing changes in drug discovery, manufacture, and marketing may ultimately spur pharmaceutical makers and health care payers to support n‐of‐1 trials, at present the most promising resuscitation strategy is stripping n‐of‐1 trials to their essentials and marketing them directly to patients. In order to optimize statistical inference from these trials, empirical Bayes methods can be used to combine individual patient data with aggregate data from comparable patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primary Care — Will It Survive?
Bodenheimer, T. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068155 · Cited by 384
Green, L. A., & Hickner, J. (2006) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.19.1.1 · Cited by 187 · cited 1×
“PBRNs are the culmination of a long research tradition in primary care pioneered by figures such as James Mackenzie, Will Pickles, John Fry, and Curtis Hames and emphasizing the careful observation of individual patients pieced together to build generalizable knowledge ( Green and Hickner 2006 ).”
Background
Cited by
Mobile Health Technology Evaluation
Kumar, S., Nilsen, W. J., Abernethy, A., Atienza, A., Patrick, K., Pavel, M., Riley, W. T., Shar, A., Spring, B., Spruijt-Metz, D., et al. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.03.017 · Cited by 900
Self-citationThe n-of-1 clinical trial: the ultimate strategy for individualizing medicine?
Lillie, E. O., Patay, B., Diamant, J., Issell, B., Topol, E. J., & Schork, N. J. (2011) · Personalized Medicine · doi:10.2217/pme.11.7 · Cited by 706
Duan, N., Kravitz, R. L., & Schmid, C. H. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.04.006 · Cited by 239
Self-citationN-of-1 Trials in the Medical Literature: A Systematic Review
Gabler, N. B., Duan, N., Vohra, S., & Kravitz, R. L. (2011) · Medical Care · doi:10.1097/mlr.0b013e318215d90d · Cited by 226
Self-citationEvaluating the Impact of Physical Activity Apps and Wearables: Interdisciplinary Review
McCallum, C., Rooksby, J., & Gray, C. M. (2018) · JMIR mhealth and uhealth · doi:10.2196/mhealth.9054 · Cited by 126
“Barriers to using rapid research designs may also be conceptual: preliminary evidence suggests that the value of, and requirements for, single-case designs were not fully understood by clinical health practitioners [184], which may also apply to mHealth researchers.”
Background
Metadata
- Authors
- KRAVITZ, R. L., DUAN, N., NIEDZINSKI, E. J., HAY, M. C., SUBRAMANIAN, S. K., & WEISNER, T. S.
- Venue
- The Milbank Quarterly
- Publisher
- Wiley
- Published
- 2008-11-21
- Volume
- 86
- Issue
- 4
- Pages
- 533-555
- ISSN
- 0887-378X (ISSN-L)
- 1468-0009
- OpenAlex
- W2086940034
- Cited by
- 97
- References
- 2
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: What Ever Happened to N‐of‐1 Trials? Insiders' Perspectives and a Look to the Future. https://app.cochat.ai/papers/10.1111/j.1468-0009.2008.00533.x
- The paper
- KRAVITZ, R. L., DUAN, N., NIEDZINSKI, E. J., HAY, M. C., SUBRAMANIAN, S. K., & WEISNER, T. S. (2008). What Ever Happened to N‐of‐1 Trials? Insiders' Perspectives and a Look to the Future. The Milbank Quarterly. https://doi.org/10.1111/j.1468-0009.2008.00533.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.